Ascentage Pharma Group International (AAPG) Minority Interest (2023 - 2025)
Ascentage Pharma Group International (AAPG) posted quarterly Minority Interest of $1.4 million for Q4 2024, down 2.19% year-over-year from $1.4 million in Q1 2024, and down 2.19% quarter-over-quarter from $1.4 million in Q4 2023.
Powered by 
Analysis
Ascentage Pharma Group International (AAPG) Minority Interest (2023 - 2025) Analysis & Trends
Ascentage Pharma Group International's Minority Interest history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2024.
- In Q4 2024, Minority Interest fell 2.19% year-over-year to $1.4 million; the TTM figure through Dec 2024 stood at $1.4 million (down 2.19% YoY), while the FY2024 annual figure was $1.4 million, down 5.5% from the prior year.
- Minority Interest for Q4 2024 stood at $1.4 million, down from $1.4 million in the prior quarter.
- The five-year high for Minority Interest was $1.4 million in Q4 2023, with the low at $1.4 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Ascentage Pharma Group International | 1.57 Bn | 1.29 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 1.42 Mn |